Fundraising Fox

AccuVein

Cold Spring Harbor, US · Delaware corporation · 1 known investors

AccuVein makes near-infrared (NIR) vein visualization devices that let clinicians see veins, valves, and bifurcations beneath the skin to guide peripheral IV insertion and vascular access. The handheld devices are used by healthcare professionals to improve first-attempt success, reduce procedure time, and lower complications.

HardwareHealthtechMedical Devices

Founders & leadership

RG
Ron GoldmanExecutive

Board

JL
James LackieBoard director
EBEric Bednarski
Eric BednarskiBoard directorPartner at MVM Life Science Partners
FF
Frank Flaut IIIBoard director
CG
Christopher GabrieliBoard director

Investors · 1

MVM Life Science PartnersreportedLondon · $20M – $100Mvia Stephen Reeders · board

Reported raises · per SEC filings

Form D private placements

$40.5M disclosed across 7 rounds · 2016–2023

▶$5.3MraisedFeb 2023 · 25 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Heather RohanDirector
  • Brian VerrierDirector
  • Kevin McArdleExecutive Officer
  • Christopher HutchisonExecutive Officer, Director
  • Akhilesh PathipatiDirector
  • Stephen ReedersDirector
  • James LackieDirector
Offering amount
$5.4M
Amount sold
$5.3M
First sale
Jan 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$17.3MraisedApr 2022 · 36 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Akhilesh PathipatiDirector
  • Brian VerrierDirector
  • Stephen ReedersDirector
  • James LackieDirector
  • Christopher HutchisonExecutive Officer, Director
  • Heather RohanDirector
  • Kevin McArdleExecutive Officer
Offering amount
$18.3M
Amount sold
$17.3M
First sale
Jul 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.5MraisedMay 2020 · 33 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Chuck JohnsonExecutive Officer
  • James LackieDirector
  • Christopher GabrieliDirector
  • Rudy MazzochiDirector
  • Ron GoldmanExecutive Officer, Director
  • Hugo HarrodDirector
Offering amount
$2.5M
Amount sold
$2.5M
First sale
Apr 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedNov 2019 · 33 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Christopher GabrieliDirector
  • Chuck JohnsonExecutive Officer
  • Ron GoldmanExecutive Officer, Director
  • James LackieDirector
  • Rudy MazzochiDirector
  • Hugo HarrodDirector
Offering amount
$2.1M
Amount sold
$2M
First sale
Oct 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8MraisedFeb 2018 · 40 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Hugo HarrodDirector
  • Christopher GabrieliDirector
  • James LackieDirector
  • Ron GoldmanExecutive Officer, Director
Offering amount
$10M
Amount sold
$8M
First sale
Jan 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.9MraisedJan 2018 · 11 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • James LackieDirector
  • Ron GoldmanExecutive Officer, Director
  • Frank Flaunt IIIDirector
  • Christopher GabrieliDirector
  • Hugo HarrodDirector
Offering amount
$2.9M
Amount sold
$2.9M
First sale
Sep 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.5MraisedDec 2016 · 28 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • James LackieDirector
  • Eric BednarskiDirector
  • Frank Flaut IIIDirector
  • Ron GoldmanExecutive Officer, Director
  • Christopher GabrieliDirector
Offering amount
$9.1M
Amount sold
$2.5M
First sale
Nov 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
ivWatch90 shared keywordsivWatch makes a continuous IV monitoring system that detects IV infiltrations and extravasations early, alerting clinical teams even when physical signs are not visible. The device is aimed at hospitals and care teams to support patient assessment protocols and reduce negative patient events.

Companies competing with AccuVein for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does AccuVein do?
AccuVein makes near-infrared (NIR) vein visualization devices that let clinicians see veins, valves, and bifurcations beneath the skin to guide peripheral IV insertion and vascular access. The handheld devices are used by healthcare professionals to improve first-attempt success, reduce procedure time, and lower complications.
Who are AccuVein's investors?
AccuVein's investors include MVM Life Science Partners.
How much funding has AccuVein raised?
AccuVein has disclosed $40.5M raised across 7 rounds.
Where is AccuVein headquartered?
AccuVein is headquartered in Cold Spring Harbor, US.